Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection

被引:16
作者
Duan, Jinyan [1 ]
Xie, Yinjing [1 ,2 ]
Yang, Jiyong [3 ]
Luo, Yanping [3 ]
Guo, Yuni [1 ]
Wang, Chengbin [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Lab, Beijing 100853, Peoples R China
[2] Shenzhen Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Microbiol, Beijing 100853, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2016年 / 22卷
关键词
Bacterial Infections; Escherichia coli Infections; Staphylococcus aureus; C-REACTIVE PROTEIN; PROCALCITONIN; BACTEREMIA; CULTURE; SEPSIS; RISK; ACTIVATION; PREDICTION; BIOMARKERS; DIAGNOSIS;
D O I
10.12659/MSM.896576
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The aim of this study was to examine the behavior of circulating inflammatory mediators and to exclude grampositive from gram-negative bloodstream infections. Results may be helpful in selection of optimal specific antibiotic therapies. Material/Methods: Mice (25-27 g) were randomized to 3 groups infected with Staphylococcus aureus (S. aureus) ATCC 25923, Escherichia coli (E. coli) ATCC 25922, or phosphate-buffered saline (PBS). The white blood cell count (WBC) and the concentrations of serum C-reactive protein (CRP), procalcitonin (PCT), interleukin (IL)-1 alpha, IL-1 beta, IL-6, IL-10, monocyte chemotactic protein-1 (MCP-1), and macrophage inflammatory protein-1 alpha (MIP-1 alpha) were detected in blood samples at different time intervals after intravenous tail injection. Results: The results showed that compared to the control mice, infected animals exhibited signicantly higher levels of all mediators after bacterial infection. Moreover, compared to the mice that received S. aureus, animals with E. coli infection showed signi.cantly greater increases in serum IL-1 alpha, IL-1 beta, IL-6, MCP-1, and MIP-1 alpha levels. Conclusions: These results suggest that the use of the analyzed serum markers at an early stage of bloodstream infection may give useful information for the clinician to distinguish gram-negative from gram-positive infections.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 48 条
  • [1] External validation of bloodstream infection mortality risk score in a population-based cohort
    Al-Hasan, M. N.
    Juhn, Y. J.
    Bang, D. W.
    Yang, H. -J.
    Baddour, L. M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (09) : 886 - 891
  • [2] Comparison of the Next-Generation Xpert MRSA/SA BC Assay and the GeneOhm StaphSR Assay to Routine Culture for Identification of Staphylococcus aureus and Methicillin-Resistant S. aureus in Positive-Blood-Culture Broths
    Buchan, Blake W.
    Allen, Stephen
    Burnham, Carey-Ann D.
    TeKippe, Erin McElvania
    Davis, Thomas
    Levi, Michael
    Mayne, Donna
    Pancholi, Preeti
    Relich, Ryan F.
    Thomson, Richard
    Ledeboer, Nathan A.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (03) : 804 - 809
  • [3] Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department
    Chiu, Chun-Wei
    Li, Ming-Chi
    Ko, Wen-Chien
    Li, Chia-Wen
    Chen, Po-Lin
    Chang, Chia-Ming
    Lee, Nan-Yao
    Lee, Ching-Chi
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2015, 48 (01) : 92 - 100
  • [4] Cytokine induction by Gram-positive bacteria
    Draing, Christian
    Sigel, Stefanie
    Deininger, Susanne
    Traub, Stephanie
    Munke, Rebekka
    Mayer, Christoph
    Hareng, Lars
    Hartung, Thomas
    von Aulock, Sonja
    Hermann, Corinna
    [J]. IMMUNOBIOLOGY, 2008, 213 (3-4) : 285 - 296
  • [5] 15d-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria
    Dugo, L
    Collin, M
    Cuzzocrea, S
    Thiemermann, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 498 (1-3) : 295 - 301
  • [6] Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria
    Feezor, RJ
    Oberholzer, C
    Baker, HV
    Novick, D
    Rubinstein, M
    Moldawer, LL
    Pribble, J
    Souza, S
    Dinarello, CA
    Ertel, W
    Oberholzer, A
    [J]. INFECTION AND IMMUNITY, 2003, 71 (10) : 5803 - 5813
  • [7] Interleukin-6 and procalcitonin in children with sepsis and septic shock
    Fioretto, Jose R.
    Martin, Joelma G.
    Kurokawa, Cilmery S.
    Carpi, Mario F.
    Bonatto, Rossano C.
    Ricchetti, Sandra M. Q.
    de Moraes, Marcos A.
    Padovani, Carlos R.
    [J]. CYTOKINE, 2008, 43 (02) : 160 - 164
  • [8] RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis
    Giacometti, A
    Cirioni, O
    Ghiselli, R
    Dell'Acqua, G
    Orlando, F
    D'Amato, G
    Mocchegiani, F
    Silvestri, C
    Del Prete, MS
    Rocchi, M
    Balaban, N
    Saba, V
    Scalise, G
    [J]. PEPTIDES, 2005, 26 (02) : 169 - 175
  • [9] Presentations from the 4th European Conference on Bloodstream Infections Athens, May 27-28 2010, Greece Introduction
    Giamarellos-Bourboulis, Evangelos J.
    Scaglione, Francesco
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 : S1 - S1
  • [10] Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000)
    Gordon, KA
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (04) : 295 - 301